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Introduction
At the macro level, the United Kingdom (UK) healthcare worker (HCW) influenza 
immunisation programme and influenza vaccines are inserted into National Health 
Service (NHS) organisations, such as NHS Trusts (England) and Health Boards 
(Wales and Scotland) by human and non-human heterogeneous actors: international
organisations (World Health Organisation, European Centre for Disease Prevention 
and Control (ECDC)); national organisations (UK Government, Welsh Assembly 
Government (WAG), National Public Health Service (NPHS), Public Health Wales 
(PHW), Health Protection Agency (HPA), Public Health England (PHE)); UK 
Legislation; Chief Medical Officers (England and Wales); national mandatory training 
(e.g. anaphylaxis) and optional training (e.g. influenza).  At the micro level, the 
programme and vaccines are inserted into healthcare workers themselves by 
heterogeneous actors, including discourses around influenza viruses and other 
diseases, influenza vaccines and other vaccines, education/training/knowledge 
about influenza and vaccines. 
A less studied area is the meso level, which can be seen to link these micro and 
macro levels.  Actor-network theory (ANT) argues that macro- and meso-level 
entities can only work and be understood at a micro-level.  As an Actor-network 
Theory (ANT) paper, the meso-level of the UK healthcare worker influenza 
immunisation programme will be analysed at a micro-level.  The meso-level here is 
understood to be the Local Health Boards (LHBs) and associated hospital institutions
where the immunisation programme is administered by (micro-level) clinical teams.  
These teams are made up of heterogeneous actors from Occupational Health, 
Emergency Planning, Infection Prevention and Control, Public Health and clinical 
hospital departments.  These actors are simultaneously actors in heterogeneous 
health professional networks, namely Medicine, Nursing and Midwifery.  
In order to produce the analysis, an ANT approach to empirical qualitative data is 
taken.  The data is drawn from 13 interviews with health professionals employed by 
two Local Health Boards (LHBs) in Wales.  The informants comprise of: Directors of 
Medicine, Nursing, Midwifery and Occupational Health; Emergency Planning and 
Infection Control Professionals; Occupational Health Nurse Managers; and, Nursing 
and Midwifery Vaccination Champions.  All of the informants are involved in planning
and/or administering the HCW influenza immunisation programme in their respective
LHBs.  It is the planning and administering of this programme which will be the focus 
of this paper.
For while the NHS HCW influenza immunisation programme has power ‘in potentia’, 
it is powerless ‘in actu’ until actors in the network perform actions, or do work in the 
net, of the NHS HCW influenza immunisation programme actor-world (Callon 1986). 
The programme only exists as long as the actors in the actor-network are enrolled 
and mobilised in it. Power is a consequence of, and not the reason for, action.
Occupational health and HCW influenza vaccination
In 2001, the then Chief Medical, Nursing and Pharmaceutical Officers for England 
declared that: ‘Responsibility for occupational influenza immunisation rests with the 
employer and it should be provided through an occupational health service’ [1].  This 
problematisation, and its associated interessement (which is not explored here), has 
resulted in NHS OH staff being enrolled as pivotal actors in the UK HCW influenza 
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immunisation network.  From this position, NHS OH staff enrol and mobilise, as 
agents of the UK government, NHS resources and other HCWs.  In addition to OH 
actors, other multi-disciplinary actors are also enrolled and act as enrollers in this 
network.
Despite this longstanding enrolment, however, OH professionals reported that they 
have only recently become mobilised as key actors within the immunisation 
programme network:
“probably for the first 10 years...I don’t even remember it being significant...I’d
say in the last 5 years maybe that’s when the flu vaccine has become more of
an issue.  It was really a take it or leave it”.
The same informant also compared the durability of this programme with the HCW 
Hepatitis B immunisation programme:
I remember Hepatitis B coming in in the late 80s, and when I joined 
Occupational Health in 1990 there was still a big drive for that.
Other OH professionals also commented on the perceived relatively recent nature of 
the HCW influenza immunisation programme; despite its duration of more than a 
decade.
This mobilisation has generated a variety of challenges, some arising from conflicts 
with the enrolment of OH staff in other networks with other requirements and some 
from the enrolment of other actors with divergent goals or motivations. Ultimately, the
immunisation programme requires OH staff to create a stable network that brings 
together a non-human actor, the vaccine, and human actors, willing frontline HCWs, 
in the same place at the same time.  
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The first challenge is to mobilise OH staff themselves.  Some are clearly ambivalent 
about the HCW vaccination programme:
I’d say there’s 1 or 2 individuals [OH professionals] who um have actually 
expressed their feelings that no we don’t agree with vaccinating, we don’t 
agree with vaccinating pregnant women...even within the Occupational Health
Department there were some individuals who were not convinced that the 
[pandemic] vaccine was that helpful.  So if you’ve got someone who says “I’m
not really sure”, if the person giving the vaccination don’t have their own 
positive commitment to it and basically you’ll end up with the person not 
having the vaccination.
OH nurses have a major role within the department in determining the planning and 
timing of vaccination campaigns:
the decision makers in that process would be predominantly be the two senior
nurse managers.  Because it’s delivered predominantly by the nursing team 
and the same with sort of ordering supplies of the vaccine in sort of April, May
or, of the preceding season if you like.
The use of OH nurses to administer in HCW vaccination campaigns was, however, 
regarded as questionable:
is that an effective use of senior nurse practitioner time because vaccinations 
can be administered by a band 5 nurse which costs a fraction of a band 7, 
band 8.  A band 7, band 8 nurse will be doing other skills whereas the band 5 
nurse will only vaccinate.  And some of the sort of team talk recently has been
“well if we have a concerted push on vaccination should we just call in agency
staff to be able to vaccinate, that’s their set purpose they get through as many
as they can”.  There were cost constraints on that and the idea was quashed. 
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But in reality if you look at it from a slightly different perspective, yeah it may 
cost a bit more money but you’re actually having a very big positive win, lots 
of people should be vaccinated because you’re more freely available.  But on 
the other hand your existing staff will be able to carry on with their normal 
work.
The use of the term ‘normal work’ by this informant presents the vaccination 
programme as something abnormal, in tension with the ‘proper work’ of the OH 
department. Another OH informant contrasted the programme with their 
department’s ‘necessary work’:
So you’ve still got to do your day to day work, you’ve still have to keep, you 
know, do the necessary work of the department.
The same informant drew attention to the role of a non-human actor, the Patient 
Group Directive (PGD)1, in destabilising the nurses’ contribution to the vaccine 
network: 
the difficulty with looking at nurses delivering the front end of the service is 
that they will not go outside that constraints of that PGD.  If they do the 
concern is well we would not be covered by our professional body, be it the 
Nursing or Midwifery Council.  We may not be covered by litigation liability 
from the trust if that person keeled over and was ill.  So having very tight 
criteria and playing by the rules as they had been written, and it being driven 
by nurses meant that you wouldn’t do it.  If we wanted someone to have a 
1 A Patient Group Direction (PGD) or Patient Specific Direction (PSD) are legal documents 
which allow qualified health professionals, who are unable to write prescriptions, to 
supply and/or administer Prescription Only Medicines (POMs) and Black Triangle Vaccines 
(in certain circumstances) (Health Service Circular, 2000/026). ‘PGDs are defined as 
written instructions for the supply or administration of medicines to groups of patients 
who may not be individually identified before presentation for treatment (SI 2000/1917)’ 
Salisbury et al, 2006: 35[2]).
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vaccination who is not in that Patient Group Directive then...a medic...would 
write a separate prescription and do it without any particular problems.
Another intrusive non-human actor is the record that OH departments are expected 
to keep ‘…of staff immunised and monitor the effectiveness of their programme’ [1] 
(pp. 4-5):
got the additional work to put the data on...the figures we’ve got to send 
to...that’s real hard work.  They’ve changed the system this year, it was really 
hard.  Before it was just a tick box, and we send the tick box form to him and 
they enter the data on it but now we’ve got to look at the denominators, we’ve
got to look what they work, which group they come into, awful time 
consuming.
The level of OH staff mobilisation is critical to the stabilisation and performance of 
the vaccination network.  Some staff are constrained by the actions of other agents 
like the Patient Group Directive (PGD).  There is competition from the claims of other
networks in which staff are enrolled: campaign timing, for example, can be affected 
by OH staff annual leave plans.  Finally, there is competition from the ‘normal’ or 
‘necessary’ work of the OH department, where staff do not share others’ view of the 
priority to be given to vaccination relative to other claims on their time and resources.
Nevertheless, some staff do succeed in ‘black-boxing’, or stabilising, their role in the 
HCW influenza immunisation programme:
We like the flu campaign because we know exactly what we’ve got to deal 
with, when it is, the timescale we’ve got to get them out and the satisfaction 
we get then because you know when we see our cohort and you see this 
heck of a list of people you vaccinated.
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Mobilisation of the OH department’s staff does not, however, ensure that the vaccine 
and the frontline HCWs will be united.  
Enrolling HCWs
The relational ontology of the vaccine programme network defines HCWs 
simultaneously as ‘consumers’, choosing to go to their OH department to be 
vaccinated every year, and as ‘recipients’, who need to be encouraged by OH staff, 
and by non-human actors such as posters, leaflets and staff intranet 
announcements, to attend for, and accept, influenza vaccination.  OH staff both 
emphasised and problematised their own role in enrolling HCWs by persuading them
to accept vaccination:
You’ve got to be assertive with them you know and I think it gives them the 
impression then that either, you know, we bully them or we really care about 
the staff and we do, we care about the staff, we don’t want them to be ill.
Similarly, OH staff complexified their role as vaccination enrollers:
I’m trying to sell patient, self and family but I think it’s family, self, patient.  So 
we started to change our tack and go “cover yourself”.  I mean I’ve always 
had the emotional blackmail but we started to change our tack to fit in with 
what we were sensing was what’s most important to this person.
While these quotes portray OH staff as caring health professionals concerned about 
the health of their HCW clients, they also exhibit concern about being perceived to 
use bullying or blackmail to achieve HCW enrolment in the vaccination programme. 
At what point does the encouragement of consumers to be recipients spill into 
coercion, with the risk of disrupting the network’s ontology? 
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This is compounded by the frequent need to enrol and mobilise ‘at a distance’ 
because OH staff have limited direct engagement with frontline HCWs. OH staff must
first enrol a variety of intermediaries, who are themselves subject to competing 
network claims and who may not necessarily appreciate the vaccine programme’s 
complex relational ontology :
You can email the heads of department, cover community, speech and 
language, occupational therapy; it’s down to the heads of department then to 
get that message out to their staff you know. And we don’t have any 
messages back; you know we don’t have the managers feeding back to us to 
say they can’t get hold of such and such.  We’re relying on managers to 
actually get it out to staff you know (Occupational Health Professional).
Some OH departments enrol specific vaccination champions, usually nurses or 
midwives working in other departments, to help encourage and/or administer HCW 
influenza vaccinations.  The use of champions was also a problem for the network 
because of the lack of control over their relationship with hybrid or non-human actors
recruited by the OH department:
But taking into account now, if you allocate a champion and then you’re going 
to provide vaccines within that area, in their fridge [for them to administer 
locally], there are a lot of details to knowing that the vaccine is stored 
properly, that a consent is filled in properly, it’s signed, that the cold chain is 
maintained you know.  And these things you’ve got to take into account.
The enrolment of frontline HCWs into the vaccination network lies, then, at the end of
an uncertain and fragile chain of actors and relationships. Complexity is further 
increased by the rationing of vaccination, which restricts enrolment to those frontline 
HCWs directly employed by the health boards. 
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we felt that, learning again from pandemic, you have a queue of people 
waiting and they got to the front and they weren’t eligible because they 
worked in an office...then they were upset and they were angry.  So that 
happened quite a lot...It’s like the haves and the have nots...we were really 
scraping the barrel to give people vaccine.
OH staff are challenged to stabilise the network by mediating between the vaccine, 
policy documents governing its usage, and potential vaccinees, whose eligibility for 
enrolment ultimately turns on practical local decisions about the fit between these 
three agents.   
Enrolling vaccines
Vaccines, as non-human actors, can only join the network if they are actually 
purchased. Their enrolment begins with instructions from another non-human actor, 
a letter from the Chief Medical Officer instructing Health Boards/Trusts to decide, 
through their OH departments, how much vaccine to order and when to order it:
It is up to individual Trusts/employers to determine their own programme and 
fund the immunisation of their staff. It is important for Occupational Health 
services to place orders for the vaccine they need as early as possible [1] (p. 
4-5).
At the same time, the recipients are also instructed that:
Vaccine for staff should not be obtained at the expense of vaccine for the risk 
groups. Staff should not be asked to go to their GP for their immunisation 
unless they fall within one of the recommended high-risk groups, or GPs have
been contracted specifically to provide this service [1] (pp. 4-5).
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The guidance simultaneously prioritises and de-prioritises the vaccine’s enrolment by
OH departments, leaving local decision-makers to resolve the conflicting 
requirements.  
In the localities studied, there seemed to have been little attempt to develop an 
explicit resolution on the enrolment of vaccines. OH departments must enrol the 
HB/Trust Medical Director to sanction payment:
The health board doesn’t shout at me for going £21,000 overspent on my 
budget on flu vaccine.  My drugs budget is continuously overspent and I say 
‘it’s for flu’ and the Medical Director said to me “If anybody picks you up on 
that...please direct them to me”.  So the health board allows Occupational 
Health to go a bit behind on its waiting times in order to deliver.  So indirectly 
the health board is very supportive of the flu vaccination programme.  How 
individuals within that [the Health Board] I don’t know.  But the Medical 
Director, Planning, Infection Control, yeah... I don’t think they’ve even begun.  
I hear a lone voice, I hear the Medical Director.
 The process by which order levels were determined was opaque, as reported by OH
professionals:
It’s usually taken on last year’s figures with a 10% upgrade.
But um it’s knowing the balance that how much do you order and how much 
wastage you have after, it’s a cost on the NHS as well.
Well historically, until this year, that’s been done by looking at the previous 
years’, and I mean more than one, uptake and trying to order to a level that 
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you would reasonably predict based on that.  So that we don’t over order and 
waste vaccine.
When asked ‘Is that seen as more of a sin than under-ordering and maybe turning 
people away?’, one response was:
I think both are really, I think it’s a no win situation.  I think it’s very difficult to 
know how best to do it.  So we’ve always ordered vaccine on the basis of sort
of anticipated uptake of a vaccine of about ten percentish, give or take a few 
percent and obviously then the situation changed during the pandemic 
campaign...But as with everything it’s a question of balancing what resources 
you’ve got and what the need is.
The OH department’s limited enrolment into the network of decision making around 
vaccine orders does not create a strong incentive for them to promote vaccination 
and increase HCW enrolment:  
I don’t think there’s any more [to be gained] in promoting the seasonal flu 
[vaccine], there’s no more that anybody could do with the health board to be 
honest with you.
The enrolment of vaccines is no more certain or stable than that of HCWs.  
The 2009-10 influenza A (H1N1) pandemic HCW immunisation programme
The 2009-10 influenza A (H1N1) pandemic was reported by OH staff to be a pivotal 
moment in the HCW influenza immunisation programme actor-network.  As an OH 
Professional stated:
pandemic was kind of like a line if you like to be crossed... the improvement 
was vertical during the pandemic and we’ve tried to keep that and build on it.
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The HCW influenza immunisation programme network is described by OH staff as a 
small engagement compared with their roles in other networks - carrying out new 
entrant screening, staff sickness absence returns, health promotion and other 
vaccinations, such as hepatitis B.  However, during the 2009-10 pandemic, more 
active mobilisation was demanded:
There was an acceptance that there would be perhaps delays if you like or 
that would have an adverse effect on some of the other things we do and 
even some things would stop whilst those services were being delivered, 
more so than happens in a seasonal campaign... Well we didn’t do any health
promotion work during the pandemic flu that I can recall.  And there would be 
some delays on perhaps, you know, sort of new entrant health screening.  I 
don’t think there were any delays that I know of caused any significant 
operational problems.  But, and routine immunisation programmes were also 
delayed a bit as well…We had to take it right through to the February, 
whereas normally the end of December would be the finish of our seasonal 
vaccines, we continued through to February.
The 2009-10 pandemic immunisation programme accentuated the challenges of the 
the seasonal programmes.  As an OH Professional contended: 
It was a significant burden really on our resources in so far as particularly it 
tied up a lot of nursing resource, both in the planning and the execution of the
campaign.
Another OH Professional went further, to contend that the HCW pandemic influenza 
campaign:
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led to people seeing Occupational Health as a vaccinating service, not being 
able to support employees with health related problems... it needs to be not 
seen as an Occupational Health focused um problem, for want of a better 
word.  It’s almost as though vaccination equals Occupational Health in the 
months of October, November, December... the department does lots of other 
things and it’s almost an expectation “well why can’t you do it, you should be 
doing it”.  And that’s almost a sort of an inclusivity or an exclusivity which isn’t 
right. This is a Health Board issue; everyone who gets paid by this health 
board has some involvement in it.
This problematisation led to a more self-conscious attempt at interessment, directed 
at managers from other departments to secure active enrolment in the network 
promoting the pandemic immunisation campaign.  Their enrolment remained 
voluntary and mobilisation was patchy.  Nevertheless OH staff saw potential long 
term implications for drawing other colleagues into the seasonal HCW immunisation 
campaign network:
You know I’m thinking about planning now our flu campaign and I’m meeting 
with our Immunisation Co-ordinator and our Emergency Planning 
Lead...Never would have thought of even, the flu campaign was our domain.  
Why would I want to meet with anybody else?  That’s what Occupational 
Health do.  So you forget that since then, like the 3 witches around a coven, 
but you find that kind of network and support and what does the Immunisation
Co-ordinator get in place and what’s Emergency Planning going to offer us 
that.  It’s changed practice, it’s just changed practice.
A bigger challenge came from changes in non-human actors, the vaccine and its 
delivery system, which required adjustments from the human actors.  The vaccine 
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now appeared in two different guises, which OH staff reported needed to be handled 
differently: 
The other thing, thinking back to that time, there were two different 
preparations I think in terms of vaccination and there were concerns 
particularly from the nurses who were administering it, you had to make it up 
with a different diluents.  Umm which again didn’t actually make it run very 
smoothly.
Where the seasonal vaccine had black-boxed the circumstances of its production 
history, the pandemic vaccine exposed these to a greater extent and made different 
demands on its human partners in administration. These were reinforced by changes
in the technical instruments for injecting the vaccine. Seasonal vaccine was supplied 
in single-dose pre-filled syringes (PFS), but the pandemic vaccine came in a ten-
dose vial, which had to be drawn up by vaccine administrators into individual 
syringes.  This was more time consuming and could lead to more wastage if the cold
chain were broken when administering the vaccine to HCWs.  Some OH staff also 
asserted that lower quality syringes and needles had been supplied. Combined with 
the greater viscosity of the pandemic vaccine, this made injections physically more 
difficult to perform.  Key informants from the nursing profession went so far as to 
suggest that repetitive strain injury (RSI) could result.  The vaccine network was 
destabilised by these changes in the action of non-human members. 
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HCW influenza immunisation programmes since the 2009-10 influenza A 
(H1N1) pandemic
Since the 2009-10 H1N1 influenza pandemic, seasonal vaccine uptake rates have 
significantly increased, according to OH informants.  A number of explanations were 
proposed.  The pandemic influenza virus A(H1N1)pdm09 was a new key actor in the 
pandemic HCW influenza immunisation programme, encouraging HCWs to enrol 
and mobilise HCWs as recipients and vaccination champions in the network.  This 
level of mobilisation has continued.  The A(H1N1)pdm09 virus has acted to stabilise 
the HCW influenza immunisation programme network by persuading HCWs that 
influenza is a serious illness that threatens them, their families and their patients.  
Previous seasonal influenza viruses failed to achieve this to the same extent.  Both 
health boards reported that OH departments were now seeking more direct 
engagement with frontline HCWs with an increased use of mobile vaccination units 
(rather than HCWs having to attend the OH department).  They were less reliant on 
enrolment at a distance. However, OH staff have also enrolled and mobilised more 
organisational partners, whether line managers or vaccine champions.  In effect they
have recognised that the problematisation that created the vaccine network needs to
be shared more widely as a means of interessement directed at key intermediaries 
between the department and the frontline HCWs whose enrolment and mobilisation 
is critical to the performance of the network. The pull of the vaccination network has 
re-shaped OH staff engagements, with implications for their mobilisation in other 
networks that are not explored here. 
During the 2011-12 winter season, both health boards were set an HCW 
immunisation target by their national Public Health service.  One health board, 
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however, decided to aim for their own, lower, target.  Key informants problematised 
the Public Health immunisation target and cast doubt on their ability to reach it.  In 
both boards, key informants questioned OH departments’ ability to reach even higher
future targets.  At the same time, OH staff were showing that the network could be 
enlarged and stabilised by the enrolment of more vaccination champions and new 
human actors in the form of agency staff to vaccinate.  
Vaccination champions
As already discussed, non- OH professionals have been involved as human actors 
doing work in this network.  Nurses and midwives working as vaccination champions 
have been considered from the point of view of OH professionals.  The work of these
non OH professionals as enrollers, champions and immunisers will now be 
considered in more detail from their own perspective.  In particular, the interviews 
with key informants and nurses and midwives working as vaccination champions in 
this network will be considered.
A non OH immuniser contended that her immunisation programme was so 
successful because she was more easily accessible to the HCWs who worked in the 
same department as her; both in terms of physical location, visibility (yellow t-shirt) 
and the times in which she was available to vaccinate.  She contended that 
geographical proximity of her immunisation service is an important factor for her 
department (which is very busy) and professional groups (whose work is 
unpredictable).  However, she also problematised the time that being constantly 
available took up but deproblematised this to some extent by reporting that her 
manager was very supportive of the time she spent on the immunisation programme.
In addition, she identified the Immunisation Co-ordinator from the LHB Infection 
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Prevention and Control Department and OH professionals to be key actors in the 
network, providing crucial support and training for vaccination champions.  
Furthermore, she contended that local knowledge of colleagues’ shift patterns 
allowed her to target unvaccinated HCWs. The vaccination champion also stated 
that she felt colleagues were more likely to accept vaccination from a colleague than 
from an OH professional because they trusted her judgement in promoting influenza 
vaccines and that she was approachable to ask any questions to.  She also 
proposed that her long experience as a midwife and in that particular department, 
good relationship with colleagues increased her perceived trustworthiness.
The vaccination champion, however, did problematise the role due to the instability 
of the network:
But you have got to keep the profile up constantly got to remind people ‘have 
you had your flu vaccination?’. You’ve constantly got to remind people ‘have 
you had your flu vaccination’, you know that sort of thing.   So it’s not just 
running the clinics it’s also keeping the profile going.
Conclusion
This paper has considered the role of macro and micro level actors enrolled in the 
UK NHS HCW influenza immunisation programme network.  These actors are linked 
at the meso level of the LHBs and hospital institutions where they do work to insert 
influenza vaccines into the hospitals and ultimately into HCWs as vaccinees.  
This network has been stabilised for the present by the actions of the 
A(H1N1)pdm09 virus, and by the threatened intervention of future influenza viruses, 
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particularly from avian sources.  OH professionals and departments remain, and will 
continue to be, key actors in this network. In addition, due to and since the 
pandemic, mobile vaccination clinics and non-OH vaccination champions have been 
enrolled and mobilised in the network.  However, the network’s stability remains 
fragile. Those organisations responsible for the problematisation that has created 
HCW influenza vaccination programmes in the UK (DH, NHS Trusts, and OH 
Departments) need to consider how the interessment of network actors, both human 
and non-human, can be sustained and translated into active enrolment and 
mobilisation. This will involve thinking about the ways in which membership in the 
vaccination network intersects with potentially competing network memberships.  
How can a cadre of human and non-human actors be sustained in ways that 
preserve a stable core to the actor-network that will facilitate rapid expansion when 
required?  Can the system achieve ‘stabilisation in advance’ [3], the creation of actor-
networks that are primed for rapid mobilisation by a newly-arrived non-human actor, 
an influenza virus with pandemic potential? 
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